江西生物：子公司兽用破伤风抗毒素生产线正式投产

财中社07-27

7月27日，江西生物（06915）发布公告，宣布其全资子公司赤峰博恩药业有限公司的兽用破伤风抗毒素生产线已于2026年7月20日在内蒙古自治区赤峰市正式投产。　　兽用破伤风抗毒素主要用于预防及治疗因外伤或手术导致的动物破伤风，能够通过中和破伤风毒素为动物提供被动免疫保护。　　此次投产标志着公司在“人用药+兽用药”双轮驱动战略方面取得了关键进展，推动了抗血清产品布局从人用领域向动物健康领域的拓展。（...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2654936130?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-27 09:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654936130","market":"sh","top_or_hot":-1,"title":"江西生物：子公司兽用破伤风抗毒素生产线正式投产","media":"财中社","content":"<div>\n<p>7月27日，江西生物（06915）发布公告，宣布其全资子公司赤峰博恩药业有限公司的兽用破伤风抗毒素生产线已于2026年7月20日在内蒙古自治区赤峰市正式投产。　　兽用破伤风抗毒素主要用于预防及治疗因外伤或手术导致的动物破伤风，能够通过中和破伤风毒素为动物提供被动免疫保护。　　此次投产标志着公司在“人用药+兽用药”双轮驱动战略方面取得了关键进展，推动了抗血清产品布局从人用领域向动物健康领域的拓展。（...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202607273821353147.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>江西生物：子公司兽用破伤风抗毒素生产线正式投产</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n江西生物：子公司兽用破伤风抗毒素生产线正式投产\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-27 09:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202607273821353147.html><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>7月27日，江西生物（06915）发布公告，宣布其全资子公司赤峰博恩药业有限公司的兽用破伤风抗毒素生产线已于2026年7月20日在内蒙古自治区赤峰市正式投产。　　兽用破伤风抗毒素主要用于预防及治疗因外伤或手术导致的动物破伤风，能够通过中和破伤风毒素为动物提供被动免疫保护。　　此次投产标志着公司在“人用药+兽用药”双轮驱动战略方面取得了关键进展，推动了抗血清产品布局从人用领域向动物健康领域的拓展。（...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202607273821353147.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06915","symbol_name":"江西生物","start_time":0,"source_url":"http://finance.eastmoney.com/a/202607273821353147.html","article_id":"2654936130","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607273821353147.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2654936130","pubTimestamp":1785114720,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"7月27日，江西生物（06915）发布公告，宣布其全资子公司赤峰博恩药业有限公司的兽用破伤风抗毒素生产线已于2026年7月20日在内蒙古自治区赤峰市正式投产。兽用破伤风抗毒素主要用于预防及治疗因外伤或手术导致的动物破伤风，能够通过中和破伤风毒素为动物提供被动免疫保护。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06915":"江西生物"},"translate_title":"Jiangxi Bio: The subsidiary's veterinary tetanus antitoxin production line was officially put into operation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06915":1.5},"content_text":"7月27日，江西生物（06915）发布公告，宣布其全资子公司赤峰博恩药业有限公司的兽用破伤风抗毒素生产线已于2026年7月20日在内蒙古自治区赤峰市正式投产。　　兽用破伤风抗毒素主要用于预防及治疗因外伤或手术导致的动物破伤风，能够通过中和破伤风毒素为动物提供被动免疫保护。　　此次投产标志着公司在“人用药+兽用药”双轮驱动战略方面取得了关键进展，推动了抗血清产品布局从人用领域向动物健康领域的拓展。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2654936130","isCrawlerRequest":true}